NEUROPACE, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
NEUROPACE, INC. (NPCE) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $2.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-11
- NEUROPACE, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $2.30M, a 28.66% decline year-over-year.
- NEUROPACE, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $2.28M, a 13.25% decline year-over-year.
- NEUROPACE, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $2.63M, a 1.43% increase year-over-year.
- NEUROPACE, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was $3.23M, a 26.69% increase year-over-year.
- NEUROPACE, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $11.09M, a 7.85% increase from fiscal 2024.
- NEUROPACE, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $10.28M, a 7.57% increase from fiscal 2023.
- NEUROPACE, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $9.56M, a 14.48% increase from fiscal 2022.
- NEUROPACE, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $8.35M, a 94.71% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.30M 10-Q · filed 2026-08-11 | $4.58M derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $2.28M 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | $11.09M 10-K · filed 2026-03-03 | |||
| 2025-09-30 | $2.63M 10-Q · filed 2025-11-04 | $5.86M derived: sum of 2 quarters · filed 2026-08-11 | $8.48M derived: sum of 3 quarters · filed 2026-08-11 | |
| 2025-06-30 | $3.23M 10-Q · filed 2026-08-11 | $5.85M derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2025-03-31 | $2.63M 10-Q · filed 2026-08-11 | |||
| 2024-12-31 | $10.28M 10-K · filed 2026-03-03 | |||
| 2024-09-30 | $2.59M 10-Q · filed 2025-11-04 | $5.14M derived: sum of 2 quarters · filed 2025-11-04 | $7.68M derived: sum of 3 quarters · filed 2025-11-04 | |
| 2024-06-30 | $2.55M 10-Q · filed 2025-11-04 | $5.09M derived: sum of 2 quarters · filed 2025-11-04 | ||
| 2024-03-31 | $2.54M 10-Q · filed 2025-11-04 | |||
| 2023-12-31 | $9.56M 10-K · filed 2025-03-04 | |||
| 2023-09-30 | $2.42M 10-Q · filed 2024-11-12 | $5.08M derived: sum of 2 quarters · filed 2024-11-12 | $7.20M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $2.65M 10-Q · filed 2024-11-12 | $4.78M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $2.13M 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $8.35M 10-K · filed 2024-03-05 | |||
| 2022-09-30 | $2.18M 10-Q · filed 2023-11-06 | $4.79M derived: sum of 2 quarters · filed 2023-11-06 | $6.27M derived: sum of 3 quarters · filed 2023-11-06 | |
| 2022-06-30 | $2.60M 10-Q · filed 2023-11-06 | $4.09M derived: sum of 2 quarters · filed 2023-11-06 | ||
| 2022-03-31 | $1.49M 10-Q · filed 2023-11-06 | |||
| 2021-12-31 | $4.29M 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $1.11M 10-Q · filed 2022-11-08 | $2.21M derived: sum of 2 quarters · filed 2022-11-08 | $2.41M derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | $1.10M 10-Q · filed 2022-11-08 | $1.30M derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-03-31 | $202.00K 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $1.38M 10-K · filed 2022-03-10 | |||
| 2020-09-30 | $301.00K 10-Q · filed 2021-11-10 | $591.00K derived: sum of 2 quarters · filed 2021-11-10 | $892.00K derived: sum of 3 quarters · filed 2021-11-10 | |
| 2020-06-30 | $290.00K 10-Q · filed 2021-11-10 | $591.00K derived: sum of 2 quarters · filed 2021-11-10 | ||
| 2020-03-31 | $301.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |